Key facts
- This page summarizes Alan J. Levy's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2024, 14:22.
Alan J. Levy - 23 Apr 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)
- Reporting relationship
- Director
- Issuer ticker
- ISRG
- Reported as of
- 23 Apr 2024
- Net transaction value
- -$432,924
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2024, 14:22:50 UTC
- Prior SEC filing
- 29 Jan 2024
- Next SEC filing
- 26 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- By: Donna Spinola For: Levy, Alan J
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan J. Levy filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 24 Apr 2024.
Change
- Previous filing in this sequence was filed on 29 Jan 2024.
- Current net transaction value: -$432,924.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ISRG
transaction
Common Stock
Options Exercise
- Transaction value
- $308,473
- Shares
- +2,000
- Change %
- +7.9%
- Price
- $154.24
- Shares after
- 27,319
- Date
- 23 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
ISRG
transaction
Common Stock
Sale
- Transaction value
- $741,398
- Shares
- -2,000
- Change %
- -7.3%
- Price
- $370.70
- Shares after
- 25,319
- Date
- 23 Apr 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISRG
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,000
- Change %
- -69%
- Price
- $0.000000
- Shares after
- 916
- Date
- 23 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000
- Exercise price
- $154.24
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.
Footnote F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.38 to $371.98 as follows: 351 shares sold at $369.38 to $369.99; 1,537 shares sold at $370.48 to $371.43; and 112 shares sold at $371.61 to $371.98. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F3
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.